These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 6358243)

  • 1. Anti-receptor antibodies mimic the effect of insulin to down-regulate insulin receptors in cultured human lymphoblastoid (IM-9) cells.
    Taylor SI; Marcus-Samuels B
    J Clin Endocrinol Metab; 1984 Jan; 58(1):182-6. PubMed ID: 6358243
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Autoantibodies to the insulin receptor. Effect on the insulin-receptor interaction in IM-9 lymphocytes.
    Flier JS; Kahn CR; Jarrett DB; Roth J
    J Clin Invest; 1977 Oct; 60(4):784-94. PubMed ID: 893677
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of Anti-Insulin Receptor Antibody on Insulin Dissociation from IM-9 lymphocytes.
    Blackard WG; Ludeman CH
    Horm Metab Res; 1981 Sep; 13(9):480-3. PubMed ID: 7028593
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The insulin receptor: characterization and regulation using insulin-antiinsulin antibody complexes as a probe for flow cytometry.
    Maron R; Kahn CR
    J Clin Endocrinol Metab; 1985 May; 60(5):1004-11. PubMed ID: 3884645
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of down-regulation of insulin receptors on receptor-antibody binding.
    Blackard WG; Sherrod J; Ludeman C
    Endocrinology; 1981 Feb; 108(2):478-83. PubMed ID: 7004857
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Insulin receptor degradation is accelerated in cultured lymphocytes from patients with genetic syndromes of extreme insulin resistance.
    McElduff A; Hedo JA; Taylor SI; Roth J; Gorden P
    J Clin Invest; 1984 Oct; 74(4):1366-74. PubMed ID: 6480829
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Insulin-like effects of anti-insulin-receptor antibodies on cultured rat hepatocytes].
    Shimoyama R
    Hokkaido Igaku Zasshi; 1985 May; 60(3):342-54. PubMed ID: 3894188
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Direct method for detection and characterization of cell surface receptors for insulin by means of 125I-labeled autoantibodies against the insulin receptor.
    Jarrett DB; Roth J; Kahn CR; Flier JS
    Proc Natl Acad Sci U S A; 1976 Nov; 73(11):4115-9. PubMed ID: 1069300
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Insulin receptor binding and degradation in IM-9 cultured human lymphocytes - importance of extracellular degradation.
    Misbin RI; Mehl TD
    J Endocrinol Invest; 1980; 3(1):77-81. PubMed ID: 6989890
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Analysis of the insulin receptor by anti-receptor antibodies and flow cytometry.
    Maron R; Jackson RA; Jacobs S; Eisenbarth G; Kahn CR
    Proc Natl Acad Sci U S A; 1984 Dec; 81(23):7446-50. PubMed ID: 6390439
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Insulin resistance and hypoglycemia in a patient with systemic lupus erythematosus: description of antiinsulin receptor antibodies that enhance insulin binding and inhibit insulin action.
    Di Paolo S; Giorgino R
    J Clin Endocrinol Metab; 1991 Sep; 73(3):650-7. PubMed ID: 1874939
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Atypical antiinsulin receptor antibodies in a patient with type B insulin resistance and scleroderma.
    Bloise W; Wajchenberg BL; Moncada VY; Marcus-Samuels B; Taylor SI
    J Clin Endocrinol Metab; 1989 Jan; 68(1):227-31. PubMed ID: 2642487
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The evolving clinical course of patients with insulin receptor autoantibodies: spontaneous remission or receptor proliferation with hypoglycemia.
    Flier JS; Bar RS; Muggeo M; Kahn CR; Roth J; Gorden P
    J Clin Endocrinol Metab; 1978 Nov; 47(5):985-95. PubMed ID: 263346
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Regulation of the insulin receptor by a monoclonal anti-receptor antibody. Evidence that receptor down regulation can be independent of insulin action.
    Roth RA; Maddux BA; Cassell DJ; Goldfine ID
    J Biol Chem; 1983 Oct; 258(20):12094-7. PubMed ID: 6355081
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Insulin receptor down-regulation, prevention at a post-receptor site.
    Filetti S; Takai NA; Rapoport B
    Endocrinology; 1981 Jun; 108(6):2409-11. PubMed ID: 6262062
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The underlying insulin receptor in patients with antireceptor autoantibodies: demonstration of normal binding and immunological properties.
    Muggeo M; Kahn CR; Bar RS; Rechler M; Flier JS; Roth J
    J Clin Endocrinol Metab; 1979 Jul; 49(1):110-9. PubMed ID: 447809
    [No Abstract]   [Full Text] [Related]  

  • 17. Syndromes of autoimmunity and hypoglycemia. Autoantibodies directed against insulin and its receptor.
    Taylor SI; Barbetti F; Accili D; Roth J; Gorden P
    Endocrinol Metab Clin North Am; 1989 Mar; 18(1):123-43. PubMed ID: 2645123
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vanadate down-regulates cell surface insulin and growth hormone receptors and inhibits insulin receptor degradation in cultured human lymphocytes.
    Torossian K; Freedman D; Fantus IG
    J Biol Chem; 1988 Jul; 263(19):9353-9. PubMed ID: 3288633
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Deletion of residues 485-599 from the human insulin receptor abolishes antireceptor antibody binding and influences tyrosine kinase activation.
    Sung CK; Wong KY; Yip CC; Hawley DM; Goldfine ID
    Mol Endocrinol; 1994 Mar; 8(3):315-24. PubMed ID: 8015549
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Insulin modulation of antibody-dependent cytotoxicity and the detection of antireceptor antibodies.
    Gelfand EW; Ipp MM; Riordan JR
    J Lab Clin Med; 1982 Jan; 99(1):39-45. PubMed ID: 7033421
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.